Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiyanping Injection in Pediatric Bronchitis
ChiCTR-IPR-16009684Phase 4Recruiting
- Sponsor
- West China Second University Hospital
- Start
- Aug 2016
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of andrographolide sulfonate in bronchitis (2 arms), sponsored by West China Second University Hospital. Primary endpoint: Time to ≥70% reduction in total clinical symptom/sign score from baseline. Started Aug 2016; status: recruiting.
02
Drugs
andrographolide sulfonate
03
Conditions
bronchitis
Beyond the preview
Go deeper on ChiCTR-IPR-16009684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009684.